On CNBC's Mad Money, Jim Cramer spoke about Merck & Co., Inc. MRK. He thinks that the stock would be trading around $65 or $66 on the good news about its drug Keytruda, if there were no political worries. If it doesn't get contested after the election, the stock is going to trade higher, thinks Cramer.
Smith & Wesson Holding Corp SWHC is a good company and there are no laws in the US that would negatively impact its performance, thinks Cramer. He sees a decent value in the stock.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in